12-53022571-C-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_ModerateBS2
The NM_001417.7(EIF4B):āc.611C>Gā(p.Ala204Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,518 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001417.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EIF4B | NM_001417.7 | c.611C>G | p.Ala204Gly | missense_variant | 6/15 | ENST00000262056.14 | NP_001408.2 | |
EIF4B | NM_001300821.3 | c.611C>G | p.Ala204Gly | missense_variant | 6/15 | NP_001287750.1 | ||
EIF4B | NM_001330654.2 | c.494C>G | p.Ala165Gly | missense_variant | 5/14 | NP_001317583.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EIF4B | ENST00000262056.14 | c.611C>G | p.Ala204Gly | missense_variant | 6/15 | 1 | NM_001417.7 | ENSP00000262056.9 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 249242Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135214
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461518Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 727078
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2024 | The c.611C>G (p.A204G) alteration is located in exon 6 (coding exon 6) of the EIF4B gene. This alteration results from a C to G substitution at nucleotide position 611, causing the alanine (A) at amino acid position 204 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at